Author:
Reinders Niels R.,van der Spek Sophie,Klaassen Remco V.,Koymans Karin J.,Li Ka Wan,Smit August B.,Kessels Helmut W.
Abstract
AbstractSoluble oligomeric amyloid-β (Aβ) is a prime suspect to cause cognitive deficits in Alzheimer’s disease and weakens synapses by removing AMPA-type glutamate receptors (AMPARs). We show that synapses of CA1 pyramidal neurons become vulnerable to Aβ when they express AMPAR subunit GluA3. We found that Aβ-oligomers reduce the levels of GluA3 immobilized at spines, indicating they deplete GluA3-containing AMPARs from synapses. These Aβ-driven effects critically depended on the PDZ-binding motif of GluA3. When GluA3 was expressed with a single amino acid mutation in its PDZ-binding motif that prevents GRIP binding, it did not end up at spines and Aβ failed to trigger synaptic depression. GluA3 with a different point mutation in the PDZ-motif that leaves GRIP-binding intact but prevents its endocytosis, was present at spines in normal amounts but was fully resistant to effects of Aβ. Our data indicate that Aβ-mediated synaptic depression requires the removal of GluA3 from synapses. We propose that GRIP-detachment from GluA3 is a critical early step in the cascade of events through which Aβ accumulation causes a loss of synapse.
Publisher
Cold Spring Harbor Laboratory
Reference41 articles.
1. Synapto-depressive effects of amyloid beta require PICK1
2. Gain-of-function mutations in protein kinase Calpha (PKCalpha) may promote synaptic defects in Alzheimer’s disease;Sci.Signal,2016
3. Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
4. A novel approach for multi-SNP GWAS and its application in Alzheimer’s disease;Alzheimer’s Disease Neuroimaging Initiative;BMC bioinformatics,2016
5. Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline